TikoMed`s drug candidate ILB inhibited infection of human cells by Dengue
07 Sep 2022 //
PRNEWSWIRE
TikoMed`s ILB® mobilizes and modulates key growth factors that trigger a cascade
31 Aug 2022 //
PRNEWSWIRE
TIKOMED, IQVIA announce strategic collaboration for TIKOMED`s lead candidate
05 May 2022 //
PRNEWSWIRE